Introduction:Chamerion angustifolium (L.) Holub (syn. Epilobium angustifolium L.) plants have been used in the treatment and alleviating symptoms of mild Benign Prostatic Hyperplasia (BPH). Plants are abundant in polyphenols, particularly ellagitannins, phenolic acids and flavonoids. Apart from polyphenols, herb of this species also contains steroids, triterpenes and fatty acids.
Objective: The aim of this study was to determine the content of campesterol, β-sitosterol and stigmasterol in C. angustifolium genotypes cultivated in vitro.
Methods: Plants grown in vitro and the plants harvested from field were subjected to the HPLC-DAD analysis.
Results: The investigated genotypes differed in sterol content. Stigmasterol (375.64–577.77 mg/100 g of dry weight – DW) was a predominant compound among the tested sterols. In contrast to in vitro cultures, plants harvested from field synthesized mainly β-sitosterol (103.05 mg/100 g DW), whereas campesterol and stigmasterol were less abundant.
Conclusions:C. angustifolium in vitro cultures are rich source of phytosterols, particularly stigmasterol. Genotype had a significant effect on phytosterol accumulation under in vitro conditions.
Introduction: Rosella (Hibiscus sabdariffa L) extract is often used as immune-stimulant because it contains flavonoids, especially anthocyanin and quercetin with antioxidant activities.
Objective: This study aimed to determine the safety of the rosella extract consumed in the form of capsules on the vital signs, haematologic parameters as well as kidney and liver function.
Methods: This research was conducted using clinical trial pre- and post-test design in healthy participants. There were 21 healthy participants (52% male, age ranged 8–45) consuming rosella capsules for thirty days, in a dose of 500 mg extract daily. Leukocytes, lymphocytes, blood urea nitrogen (BUN), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and vital signs were consecutively evaluated on days 0, 31, and 45, respectively. The Wilcoxon and paired sample t-test were used to compare the parameters among the evaluated times.
Results: The result showed that no significant difference for all parameters among the three time points (p>0.05).
Conclusion: These findings suggested that the administration of ethanolic extract of rosella is potential safe and does not negatively affect the vital signs, haemoglobin, leukocytes, lymphocytes, BUN, SGOT, and SGPT.
Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation with eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) known as omega-3 polyunsaturated fatty acids (FAs), commonly called fish oils, on the occurrence of cardiovascular diseases. In a living organism, omega-3 FA (EPA and DHA) and omega-6 FA (arachidonic acid [AA]) are also involved in the formation of key regulators of platelet aggregation, vasodilation and inflammation. It is important to know that EPA and DHA act in different ways on membrane structure and lipid metabolism. For this reason, combining DHA with EPA may modify the clinical effects of only EPA treatment. The effects of omega-3 FAs on cardiovascular system remain uncertain. Two recent negative trials of EPA + DHA, STRENGTH and OMEMI, have put the utility of omega-3 FAs in preventing atherosclerotic cardiovascular events under debate. This paper presents the actual knowledge on the role of polyunsaturated acids in cardiovascular diseases.
In Poland, food supplements have been popular among consumers for many years. Their sale brings producers huge profits. The interest in these products, especially in vitamin and mineral preparations and in immunity-supporting products increased dramatically due to the COVID-19 pandemic. Self-medication with untested dietary supplements may be health hazardous. Since in Poland and in other countries the procedures of quality control of food supplements are imperfect, this situation raises serious concerns about the risks of their unrestricted use and food fraud. The article briefly presents important problems in the safety of food supplements from the point of view of experts involved in their evaluation.
Introduction:Chamerion angustifolium (L.) Holub (syn. Epilobium angustifolium L.) plants have been used in the treatment and alleviating symptoms of mild Benign Prostatic Hyperplasia (BPH). Plants are abundant in polyphenols, particularly ellagitannins, phenolic acids and flavonoids. Apart from polyphenols, herb of this species also contains steroids, triterpenes and fatty acids.
Objective: The aim of this study was to determine the content of campesterol, β-sitosterol and stigmasterol in C. angustifolium genotypes cultivated in vitro.
Methods: Plants grown in vitro and the plants harvested from field were subjected to the HPLC-DAD analysis.
Results: The investigated genotypes differed in sterol content. Stigmasterol (375.64–577.77 mg/100 g of dry weight – DW) was a predominant compound among the tested sterols. In contrast to in vitro cultures, plants harvested from field synthesized mainly β-sitosterol (103.05 mg/100 g DW), whereas campesterol and stigmasterol were less abundant.
Conclusions:C. angustifolium in vitro cultures are rich source of phytosterols, particularly stigmasterol. Genotype had a significant effect on phytosterol accumulation under in vitro conditions.
Introduction: Rosella (Hibiscus sabdariffa L) extract is often used as immune-stimulant because it contains flavonoids, especially anthocyanin and quercetin with antioxidant activities.
Objective: This study aimed to determine the safety of the rosella extract consumed in the form of capsules on the vital signs, haematologic parameters as well as kidney and liver function.
Methods: This research was conducted using clinical trial pre- and post-test design in healthy participants. There were 21 healthy participants (52% male, age ranged 8–45) consuming rosella capsules for thirty days, in a dose of 500 mg extract daily. Leukocytes, lymphocytes, blood urea nitrogen (BUN), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and vital signs were consecutively evaluated on days 0, 31, and 45, respectively. The Wilcoxon and paired sample t-test were used to compare the parameters among the evaluated times.
Results: The result showed that no significant difference for all parameters among the three time points (p>0.05).
Conclusion: These findings suggested that the administration of ethanolic extract of rosella is potential safe and does not negatively affect the vital signs, haemoglobin, leukocytes, lymphocytes, BUN, SGOT, and SGPT.
Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation with eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) known as omega-3 polyunsaturated fatty acids (FAs), commonly called fish oils, on the occurrence of cardiovascular diseases. In a living organism, omega-3 FA (EPA and DHA) and omega-6 FA (arachidonic acid [AA]) are also involved in the formation of key regulators of platelet aggregation, vasodilation and inflammation. It is important to know that EPA and DHA act in different ways on membrane structure and lipid metabolism. For this reason, combining DHA with EPA may modify the clinical effects of only EPA treatment. The effects of omega-3 FAs on cardiovascular system remain uncertain. Two recent negative trials of EPA + DHA, STRENGTH and OMEMI, have put the utility of omega-3 FAs in preventing atherosclerotic cardiovascular events under debate. This paper presents the actual knowledge on the role of polyunsaturated acids in cardiovascular diseases.
In Poland, food supplements have been popular among consumers for many years. Their sale brings producers huge profits. The interest in these products, especially in vitamin and mineral preparations and in immunity-supporting products increased dramatically due to the COVID-19 pandemic. Self-medication with untested dietary supplements may be health hazardous. Since in Poland and in other countries the procedures of quality control of food supplements are imperfect, this situation raises serious concerns about the risks of their unrestricted use and food fraud. The article briefly presents important problems in the safety of food supplements from the point of view of experts involved in their evaluation.